REBECA
VIDAL CASADO
Profesora ayudante doctora
Centro de Investigacion Biomedica en Red de Salud Mental
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro de Investigacion Biomedica en Red de Salud Mental (17)
2021
-
5-HT4Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression
ACS Chemical Neuroscience, Vol. 12, Núm. 11, pp. 2036-2044
2020
-
β-Catenin Role in the Vulnerability/Resilience to Stress-Related Disorders Is Associated to Changes in the Serotonergic System
Molecular Neurobiology, Vol. 57, Núm. 3, pp. 1704-1715
2019
-
Targeting β-Catenin in GLAST-Expressing Cells: Impact on Anxiety and Depression-Related Behavior and Hippocampal Proliferation
Molecular Neurobiology, Vol. 56, Núm. 1, pp. 553-566
2018
-
Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome
Molecular Neurobiology, Vol. 55, Núm. 6, pp. 4745-4762
2017
-
Enhanced Stress Response in 5-HT1AR Overexpressing Mice: Altered HPA Function and Hippocampal Long-Term Potentiation
ACS Chemical Neuroscience, Vol. 8, Núm. 11, pp. 2393-2401
-
The Addiction-Related Protein ANKK1 is Differentially Expressed During the Cell Cycle in Neural Precursors
Cerebral Cortex, Vol. 27, Núm. 5, pp. 2809-2819
2016
-
Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: Role of 5-HT1A receptors
Neuropharmacology, Vol. 103, pp. 16-26
-
The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor
Neuropharmacology, Vol. 111, pp. 47-58
-
Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration
Molecular Psychiatry, Vol. 21, Núm. 3, pp. 328-338
2015
-
Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures
Oncotarget, Vol. 6, Núm. 28, pp. 25452-25465
-
Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes
Cancer Cell, Vol. 28, Núm. 2, pp. 170-182
2014
-
Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of down syndrome
PLoS ONE, Vol. 9, Núm. 9
-
Signaling pathways involved in antidepressant-induced cell proliferation and synaptic plasticity
Current Pharmaceutical Design, Vol. 20, Núm. 23, pp. 3776-3794
2013
-
Neural plasticity and proliferation in the generation of antidepressant effects: Hippocampal implication
Neural Plasticity, Vol. 2013
2012
-
Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT 4 receptor agonist RS67333
International Journal of Neuropsychopharmacology, Vol. 15, Núm. 5, pp. 631-643
-
Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects
British Journal of Pharmacology, Vol. 165, Núm. 4 B, pp. 1046-1057
2010
-
Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine1A receptor-dependent mechanisms
Molecular Pharmacology, Vol. 77, Núm. 3, pp. 424-434